WallStSmart

National Health Investors Inc (NHI)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 1434% more annual revenue ($5.82B vs $379.29M). NHI leads profitability with a 37.5% profit margin vs 4.3%. VTR appears more attractively valued with a PEG of 1.74. VTR earns a higher WallStSmart Score of 55/100 (C).

NHI

Hold

48

out of 100

Grade: D+

Growth: 4.0Profit: 8.0Value: 4.7Quality: 7.5
Piotroski: 3/9Altman Z: 2.46

VTR

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.8
Piotroski: 4/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NHISignificantly Overvalued (-329.6%)

Margin of Safety

-329.6%

Fair Value

$20.54

Current Price

$83.12

$62.58 premium

UndervaluedFair: $20.54Overvalued
VTRSignificantly Overvalued (-591.0%)

Margin of Safety

-591.0%

Fair Value

$12.40

Current Price

$82.70

$70.30 premium

UndervaluedFair: $12.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NHI3 strengths · Avg: 9.3/10
Profit MarginProfitability
37.5%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
62.5%10/10

Strong operational efficiency at 62.5%

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

VTR2 strengths · Avg: 8.0/10
Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

NHI4 concerns · Avg: 2.8/10
P/E RatioValuation
27.3x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.762/10

Expensive relative to growth rate

Revenue GrowthGrowth
-11.7%2/10

Revenue declined 11.7%

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NHI

The strongest argument for NHI centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 37.5% and operating margin at 62.5%.

Bull Case : VTR

The strongest argument for VTR centers on Operating Margin, Revenue Growth. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : NHI

The primary concerns for NHI are P/E Ratio, Piotroski F-Score, PEG Ratio.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.2x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

NHI profiles as a declining stock while VTR is a growth play — different risk/reward profiles.

VTR carries more volatility with a beta of 0.76 — expect wider price swings.

VTR is growing revenue faster at 21.4% — sustainability is the question.

VTR generates stronger free cash flow (368M), providing more financial flexibility.

Bottom Line

VTR scores higher overall (55/100 vs 48/100) and 21.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

National Health Investors Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?